Blog

Evidence-based thinking and why it matters
Views expressed may represent the views of the author and not necessarily those of CEBM as a group

What do patients really want? Reflections post-Evidence Live.

At Evidence Live 2016, attendees heard from patients, policy makers and researchers about the current challenges to integrating the best

Read More

Diet Wars - Is There Any Hope?

“Butter is back.” “Butter is not back.” “The dietary guidelines are killing us.” “The dietary guidelines are good for us.” Confused?

Read More

Oil Pulling: Does it work? Anecdotally, yes; but the jury is still out in this review.

Open Sesame! You will be forgiven for never having heard of oil pulling. I only recently stumbled upon it, when

Read More

Can Education Learn from Evidence-Based Medicine?

As a primary school teacher turned education researcher I was delighted to have been invited to attend Evidence Live (see

Read More

Tutor Profiles

EBHC Tutor Profiles In this new interview series, we get to know tutors involved in teaching EBM the MSc in

Read More

Insights for the Next Generation of Leaders

Evidence Live 2016 was a resounding success, bringing together global leaders in evidence-based medicine along with 300 delegates. An important

Read More

Beware evidence “spin” : an important source of bias in the reporting of clinical research

Evidence Live 2016 begins this week, with 3 full days of discussion and learning around 5 main themes including  “Transforming

Read More

When medicine meets marketing: turmeric tea and other ‘wonder herbs’

Wouldn’t it be fantastic if a cup of tea could cure all that ails you? I mean really cure you,

Read More

Oseltamivir and mortality: Why do the conclusions of Muthuri et al (2014) differ from Heneghan et al (2016)

“There are a number of possible methodological reasons why the conclusions could be so different.” Muthuri et al published a

Read More

Defining collaborative care as an alternative model to patient-centred care

  Some ideas seem so obviously right that they appear to deny the possibility of harmful or counterproductive consequences. But

Read More

Big Pharma and Big Medicine: An Agenda for Collaboration

It is misleading to refer, as many do, to “the pharmaceutical industry”, since there is no such thing as a

Read More

Timeline of events since the publication of Cochrane Review on Neuraminidase Inhibitors

Compiled by Tom Jefferson, Peter Doshi, Mark Jones, Rokuro Hama and Carl Heneghan This time line charts significant events since

Read More

When I Use an Evidence Based Word . . .

4. From phonemes to roots If words can be traced back to roots, as I discussed in Part 3, so

Read More

Pearls of wisdom for future leaders

Recently I had the opportunity to attend an annual research competition which brought together paediatric trainees from across Canada. It

Read More